Fenwick & West advised Vanqua Bio on the deal. Vanqua Bio, a biopharmaceutical company dedicated to discovering and developing next-generation medicines for neurodegenerative diseases, announced its $85...
Vanqua Bio’s $85 Million Series B Financing
T-knife Therapeutics’ $110 Million Series B Financing
Fenwick & West advised T-knife Therapeutics on the deal. Torys LLP acted as counsel to Sixty Degree Capital. T-knife Therapeutics, Inc., a next-generation T-cell receptor company...